Allen Chao
Asia, T'ai-pei, Taiwan'/%3e%3cuse xlink:href='%23a' transform='rotate(60)'/%3e%3ccircle r='17' fill='%23000095'/%3e%3ccircle r='15' fill='%23fff'/%3e%3c/svg%3e)
Description
Dr. Chao was a co-founder of Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, serving as a director from 1985 to May 2008, ...
Investor Profile
Allen Chao has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series B rounds (top funding stages).
- Majority of deals are located in United States, Taiwan.
- Strong thematic focus on Biotechnology, Medical, Artificial Intelligence (AI).
Stage Focus
- Seed (50%)
- Series B (50%)
Country Focus
- United States (50%)
- Taiwan (50%)
Industry Focus
- Biotechnology
- Medical
- Artificial Intelligence (Ai)
- Biopharma
- Health Care
- Health Diagnostics
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
